Cedar Wealth Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-24,519
Closed -$387K 390
2021
Q4
$387K Buy
24,519
+12,886
+111% +$309K 0.16% 93
2021
Q3
$374K Buy
11,633
+1,940
+20% +$68.2K 0.17% 84
2021
Q2
$403K Buy
9,693
+180
+2% +$7.39K 0.18% 81
2021
Q1
$483K Sell
9,513
-887
-9% -$46.4K 0.24% 74
2020
Q4
$337K Buy
+10,400
New +$147K 0.18% 76

Other funds holding DMTK

Cedar Wealth Management's DMTK Position: Q1 2022 in Review

Cedar Wealth Management sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2022, closing a stake of 24,519 shares — an estimated $387K sold.

Cedar Wealth Management first reported a position in DMTK in Q4 2020 and held it in 5 quarters. The position peaked at $483K in Q1 2021. 151 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

  • Cedar Wealth Management reported no remaining DermTech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Cedar Wealth Management sold 24,519 DermTech, Inc. Common Stock shares in Q1 2022, an estimated $387K.
  • Cedar Wealth Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Cedar Wealth Management's DermTech, Inc. Common Stock position peaked at $483K in Q1 2021.
  • 151 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Cedar Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.